Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Shares Issued (2016 - 2025)

Historic Shares Issued for Amphastar Pharmaceuticals (AMPH) over the last 12 years, with Q3 2025 value amounting to $379000.0.

  • Amphastar Pharmaceuticals' Shares Issued changed N/A to $379000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year change of. This contributed to the annual value of $11.0 million for FY2023, which is 2991.44% down from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its Shares Issued stood at $379000.0 for Q3 2025.
  • Amphastar Pharmaceuticals' Shares Issued's 5-year high stood at $5.7 million during Q4 2021, with a 5-year trough of $379000.0 in Q3 2025.
  • Over the past 4 years, Amphastar Pharmaceuticals' median Shares Issued value was $2.1 million (recorded in 2023), while the average stood at $2.7 million.
  • In the last 5 years, Amphastar Pharmaceuticals' Shares Issued soared by 20550.46% in 2021 and then tumbled by 6399.93% in 2022.
  • Amphastar Pharmaceuticals' Shares Issued (Quarter) stood at $5.7 million in 2021, then plummeted by 64.0% to $2.0 million in 2022, then surged by 74.68% to $3.6 million in 2023, then tumbled by 89.35% to $379000.0 in 2025.
  • Its last three reported values are $379000.0 in Q3 2025, $3.6 million for Q4 2023, and $2.1 million during Q3 2023.